Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huisheng oral solution after radical surgery for stage II–IIIb NSCLC
ChiCTR2100046941Phase 4Recruiting
- Sponsor
- Sichuan Provincial People's Hospital
- Start
- Jun 2021
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Huisheng Oral Liquid in non-small cell lung cancer (NSCLC), sponsored by Sichuan Provincial People's Hospital. Primary endpoint: Progression-free survival. Started Jun 2021; status: recruiting.
02
Drugs
Huisheng Oral Liquid
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ChiCTR2100046941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046941.